Autophagy–ferroptosis crosstalk in sepsis: metabolic pathways, redox injury, and host-directed antioxidant nanomedicine - Scorecard - MDSpire

Autophagy–ferroptosis crosstalk in sepsis: metabolic pathways, redox injury, and host-directed antioxidant nanomedicine

  • By

  • Yang Huang

  • Shi Feng

  • Jiaqi Wang

  • Fan Yi

  • Yuhong Gao

  • May 28, 2026

  • 0 min

Share

Clinical Scorecard: Interactions Between Autophagy and Ferroptosis in Sepsis: Implications for Metabolic Pathways, Oxidative Damage, and Antioxidant Nanomedicine Approaches

At a Glance

CategoryDetail
ConditionSepsis
Key MechanismsAutophagy and ferroptosis interplay affecting oxidative stress and tissue injury.
Target PopulationPatients with sepsis experiencing organ dysfunction.
Care SettingClinical settings managing sepsis.

Key Highlights

  • Sepsis is characterized by oxidative stress leading to organ dysfunction.
  • Ferroptosis is a regulated necrotic cell death linked to iron-dependent lipid peroxidation.
  • Autophagy modulates ferroptosis susceptibility through iron metabolism and mitochondrial quality control.
  • Nanomedicine approaches may enhance targeted antioxidant delivery in sepsis.
  • Precision redox modulation is essential for effective sepsis management.

Guideline-Based Recommendations

Diagnosis

  • Recognize sepsis as life-threatening organ dysfunction due to dysregulated host response to infection.

Management

  • Target core mechanisms of tissue injury while preserving antimicrobial defenses.

Monitoring & Follow-up

  • Evaluate biochemical readouts and autophagy flux in sepsis patients.

Risks

  • Late-stage oxidative stress can lead to multi-organ failure.

Patient & Prescribing Data

Patients with sepsis and associated oxidative stress.

Engineered nanomedicines may improve pharmacokinetics and targeting of antioxidants.

Clinical Best Practices

  • Implement mechanism-guided interventions for oxidative stress in sepsis.
  • Utilize biomarker-guided patient stratification for tailored therapies.
  • Focus on compartment-specific delivery of therapeutics.

Related Resources & Content

Original Source(s)

Related Content